Of notable importance, agonism of the co-stimulatory CD27-CD70 pathway, a member of the TNF superfamily, has been studied as a potential therapeutic intervention as an oncologic therapy for multiple tumor cell types as well as a therapeutic intervention to attenuate GVHD. This evidence concerns the gene CD70 and neoplasm.